CD19 as an attractive target for antibody-based therapy
Author:
Publisher
Informa UK Limited
Subject
Immunology,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.4161/mabs.21338
Reference61 articles.
1. Rituximab for the treatment of non-Hodgkin’s lymphoma and chronic lymphocytic leukaemia;Hagemeister;Drugs,2010
2. Antibody-drug conjugates for the treatment of non-Hodgkin’s lymphoma: target and linker-drug selection;Polson;Cancer Res,2009
3. Action of novel CD37 antibodies on chronic lymphocytic leukemia cells;Krause;Leukemia,2012
4. Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study;Kantarjian;Lancet Oncol,2012
5. Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas;Gerber;Blood,2009
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies;Blood;2024-08-15
2. Blinatumomab vs Chemotherapy for Pediatric and Adult Acute Lymphoblastic Leukemia;OBM Genetics;2024-07-19
3. A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis;European Journal of Neurology;2024-05-10
4. Deciphering stage 0 hematogones by flow cytometry in follow‐up bone marrow samples of pediatric B—Acute lymphoblastic leukemia cases: A potential mimicker of residual disease after anti CD19 therapy;Cytometry Part B: Clinical Cytometry;2024-01-19
5. Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display;Journal of Translational Medicine;2023-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3